WisdomTree BioRevolution Fund (BATS:WDNA) Shares Up 1.4% – Here’s Why

Shares of WisdomTree BioRevolution Fund (BATS:WDNA) were up 1.4% on Wednesday . The company traded as high as $20.22 and last traded at $20.22. Approximately 653 shares traded hands during trading, a decline of 31% from the average session volume of 946 shares. The stock had previously closed at $19.95.

WisdomTree BioRevolution Fund Price Performance

The stock has a market capitalization of $3.03 million, a price-to-earnings ratio of 17.03 and a beta of 1.01. The firm’s fifty day moving average is $19.48 and its 200-day moving average is $18.38.

Institutional Investors Weigh In On WisdomTree BioRevolution Fund

A hedge fund recently raised its position in WisdomTree BioRevolution Fund stock. Jane Street Group LLC grew its stake in WisdomTree BioRevolution Fund (BATS:WDNA) by 45.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,864 shares of the company’s stock after purchasing an additional 5,306 shares during the quarter. Jane Street Group LLC owned approximately 11.24% of WisdomTree BioRevolution Fund worth $231,000 as of its most recent filing with the SEC.

About WisdomTree BioRevolution Fund

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.